Human Reproduction, Vol. 17, No. 8, 2209-2213,
August 2002
© 2002 European Society of Human Reproduction and Embryology
Cancer incidence following treatment for infertility at a clinic in the UK
1 Epidemiology Unit, Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, University of London, Keppel St, London WC1E 7HT, 2 Imperial Cancer Research Fund, University of Oxford, Gibson Building, Radcliffe Infirmary, Oxford OX2 6HE, 3 Section of Epidemiology, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK and 4 Department of Obstetrics and Gynaecology, McGill University, Royal Victoria Hospital, Montreal, Canada
BACKGROUND: There is concern about the long-term health impact of ovarian stimulation treatment for infertility, in particular the effect on cancer risk. The aim of this study was to investigate the incidence of cancer in a cohort of women attending a large infertility clinic in the UK. METHODS: Women who were UK residents attending the clinic between January 1, 1975 and December 31, 1989 were identified for the study. The cohort was followed-up and cancer incidence rates calculated. RESULTS: The study cohort was made up of 5556 women of whom 75% had received ovarian stimulation drug treatment at the clinic. A total of 118 cancers (including 55 breast, four corpus uteri and six ovarian) were incident in the cohort from the beginning of 1990 to the end of 1997. The incidence rates of cancer of the breast, corpus uteri and ovary were not significantly different from expectation based on national cancer rates, and were similar for women who had received hormonal treatment to stimulate their ovaries and those who had not. CONCLUSIONS: These data do not support a hypothesis linking infertility treatment involving ovarian stimulation with increased breast, uterine and ovarian cancer over the follow-up period studied.
Key words: cancer incidence/infertility treatment/ovarian stimulation
5 To whom correspondence should be addressed. E-mail: pat.doyle{at}lshtm.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Jensen, H. Sharif, J. H. Olsen, and S. K. Kjaer Risk of Breast Cancer and Gynecologic Cancers in a Large Population of Nearly 50,000 Infertile Danish Women Am. J. Epidemiol., July 1, 2008; 168(1): 49 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Pappo, L. Lerner-Geva, A. Halevy, L. Olmer, S. Friedler, A. Raziel, M. Schachter, and R. Ron-El The Possible Association between IVF and Breast Cancer Incidence Ann. Surg. Oncol., April 1, 2008; 15(4): 1048 - 1055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jensen, H. Sharif, E. I. Svare, K. Frederiksen, and S. K. Kjaer Risk of Breast Cancer After Exposure to Fertility Drugs: Results from a Large Danish Cohort Study Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1400 - 1407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Choi, A. S. T. Wong, H.-F. Huang, and P. C. K. Leung Gonadotropins and Ovarian Cancer Endocr. Rev., June 1, 2007; 28(4): 440 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kristiansson, O. Bjor, and H. Wramsby Tumour incidence in Swedish women who gave birth following IVF treatment Hum. Reprod., February 1, 2007; 22(2): 421 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Terry, W. C. Willett, J. W. Rich-Edwards, and K. B. Michels A Prospective Study of Infertility Due to Ovulatory Disorders, Ovulation Induction, and Incidence of Breast Cancer Arch Intern Med, December 11, 2006; 166(22): 2484 - 2489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. KANAKAS and T. MANTZAVINOS Fertility Drugs and Gynecologic Cancer Ann. N.Y. Acad. Sci., December 1, 2006; 1092(1): 265 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Althuis, K. S. Moghissi, C. L. Westhoff, B. Scoccia, E. J. Lamb, J. H. Lubin, and L. A. Brinton Uterine Cancer after Use of Clomiphene Citrate to Induce Ovulation Am. J. Epidemiol., April 1, 2005; 161(7): 607 - 615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gauthier, X. Paoletti, F. Clavel-Chapelon, and and the E3N group Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study Hum. Reprod., October 1, 2004; 19(10): 2216 - 2221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Brinton, B. Scoccia, K. S. Moghissi, C. L. Westhoff, M. D. Althuis, J. E. Mabie, and E. J. Lamb Breast cancer risk associated with ovulation-stimulating drugs Hum. Reprod., September 1, 2004; 19(9): 2005 - 2013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Brinton, E. J. Lamb, K. S. Moghissi, B. Scoccia, M. D. Althuis, J. E. Mabie, and C. L. Westhoff Ovarian Cancer Risk After the Use of Ovulation-Stimulating Drugs Obstet. Gynecol., June 1, 2004; 103(6): 1194 - 1203. [Abstract] [Full Text] [PDF]
|
|